Medifocus Inc V.MFS

Primary Symbol: MDFZF

Healthcare Biotechnology

Medifocus Inc develops and sells minimally invasive focused heat systems for the treatment of cancerous and benign tumors, and enlarged prostate, medically known as Benign Prostate Hyperplasia (BHP). It owns two focused heat technology platforms, The Endo-thermotherapy Platform-from which Prolieve was developed, can be used to treat cancers in prostate, rectal, cervical and esophageal, and The Adaptive Phased Array Microwave Focusing Platform which directs precisely focused microwave energy at tumor center to induce shrinkage or eradication of tumors without undue harm to surrounding tissue. The company through its operations generates revenue from the United States.

EXPM:MDFZF - Post by User

Medifocus Inc

Bullboard Posts

Comment by bayoubuckson Jan 05, 2014 11:24am

176 Views

Post# 22059551

RE:RE:good article MFS

Nice article, but the author failed to consider the 82 million shares in warrants and options outstanding.
When you start calculating EPS, shouldn't you figure it on a fully diluted basis also? This doesn't include the futher dilution from the current financing. Don't get me wrong, I own a fair amount and will continue to add on dips as the potential is huge. Just thought that needed clearing up.

Bullboard Posts

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide